Comparing transarterial chemoembolization alone to combined transarterial chemoembolization and radiofrequency ablation in primary hepatocellular carcinoma treatment

Figure 1 The Kaplan-Meier survival curves for patients with primary hepatocellular carcinoma treated with transarterial chemoembolization and transarterial chemoembolization combined with radiofrequency ablation. The curves depict the differences in survival rates between the two treatment modalities, with the transarterial chemoembolization + radiofrequency ablation group demonstrating a significantly prolonged median survival time compared to the transarterial chemoembolization group. TACE: Transarterial chemoembolization; RFA: Radiofrequency ablation.